Effectiveness and Implementation of a Personalized mHealth Intervention for the Universal Prevention of Maternal Perinatal Mental Disorders (ePerinatal-RCT)
25. Mai 2026 aktualisiert von: Emma Motrico, University of Seville
Universal Prevention of Maternal Perinatal Mental Disorders and Its Implementation as Normalized Routine Practice (e-Perinatal): A Cluster Randomized Hybrid Effectiveness-Implementation Trial
This study is part of the ERC-funded e-Perinatal project and represents a large-scale hybrid type 1 effectiveness-implementation cluster randomized controlled trial.
The primary aim is to evaluate the effectiveness of a personalized and complex mobile health (mHealth) intervention (e-Perinatal) in the universal prevention of maternal perinatal depression and anxiety disorders.
Secondary aims include evaluating the impact on paternal mental health and child development, as well as examining implementation outcomes in real-world primary healthcare settings.
Studienübersicht
Status
Noch keine Rekrutierung
Bedingungen
Detaillierte Beschreibung
This clinical trial evaluates the effectiveness and implementation of the e-Perinatal intervention, a personalized mobile health (mHealth) psychological program designed for the universal prevention of maternal perinatal depression and anxiety disorders. The study will be conducted as a two-arm, cluster-randomized, hybrid type 1 effectiveness-implementation trial in routine maternal care settings within primary healthcare centers.
Primary healthcare centers will be randomized to either the intervention or control arm. Participants will include pregnant women and their partners.
The primary objective is to evaluate the effectiveness of the e-Perinatal intervention in reducing the cumulative incidence of maternal perinatal depression and anxiety disorders, assessed via structured diagnostic interviews. Secondary objectives include assessing maternal and paternal mental health outcomes, child development outcomes, and identifying moderators and mediators of intervention effectiveness.
In addition, the study will evaluate implementation outcomes, including acceptability, feasibility, adoption, fidelity, and barriers and facilitators to implementation in real-world healthcare settings.
Participants in the intervention group will receive access to the e-Perinatal app alongside usual maternal care. The e-Perinatal app includes: 1) Digital micro-interventions focused on psychological, physical activity, and healthy lifestyle domains; 2) a personalized recommendation engine; 3) a social support section; 4) mental health monitoring; 5) an 'SOS' button for assistance; and 6) an appointment reminder tool. Participants in the control group will receive usual maternal care.
Studientyp
Interventionell
Einschreibung (Geschätzt)
3000
Phase
- Unzutreffend
Kontakte und Standorte
Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.
Studienkontakt
- Name: Emma Motrico, PhD Psychology
- Telefonnummer: 0034636995778
- E-Mail: eperinatal@us.es
Teilnahmekriterien
Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.
Zulassungskriterien
Studienberechtigtes Alter
- Erwachsene
- Älterer Erwachsener
Akzeptiert gesunde Freiwillige
Ja
Beschreibung
Inclusion Criteria:
- Inclusion Criteria (Women)
Must receive an invitation to participate from a healthcare professional at one of the participating primary healthcare centers
Must be pregnant for at least 11 weeks at the time of enrollment
Must be at least 18 years old
Must have access to a mobile phone and internet connection
Must be able to read, write, and understand Spanish
Must have a personal email account
No diagnosis of depression or anxiety disorder at baseline Forma
- Inclusion Criteria (Partners or significant others)
Must receive an invitation to participate from a woman already enrolled in the study
Must be at least 18 years old
Must have access to a mobile phone and internet connection
Must be able to read, write, and understand Spanish
Must have a personal email account
Exclusion Criteria:
- Exclusion Criteria (Women)
Current diagnosis of depression or anxiety disorder
Receiving psychological or pharmacological treatment for mental health or substance use conditions
- Exclusion criteria for partners (or significant others):
There are no exclusion criteria for partners
Studienplan
Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Verhütung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Single
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: Interventionsgruppe
|
The e-Perinatal intervention is a personalized mobile health (mHealth) program that includes: 1) Digital micro-interventions focused on psychological, physical activity, and healthy lifestyle domains; 2) a personalized recommendation engine; 3) a social support section; 4) mental health monitoring; 5) an 'SOS' button for assistance; and 6) an appointment reminder tool. The intervention is delivered through a mobile application and is integrated into routine maternal care. Participants will use the app from recruitment (pregnancy) until 12 months of postpartum. |
|
Aktiver Komparator: Kontrollgruppe
|
Participants will receive standard maternal care as provided by the public healthcare system, including routine antenatal and postnatal visits and access to maternal education programs.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Cumulative incidence of maternal perinatal depression and anxiety disorders
Zeitfenster: Baseline and 12 months postpartum
|
Assessment method: Composite Internacional Diagnosis Interview (CIDI), based on DSM-5 criteria
|
Baseline and 12 months postpartum
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Maternal depressive symptoms (mothers)
Zeitfenster: Baseline, 34-36 weeks of gestation (for participants enrolled before 31 weeks), 6 weeks postpartum, and 6, 12, and 18 months postpartum
|
Changes in depressive symptoms.
Assessment method: The Edinburgh Postnatal Depression Scale (EPDS), a 10-item self-report measure.
Each item is scored from 0 to 3, with higher scores indicating more severe depressive symptoms.
|
Baseline, 34-36 weeks of gestation (for participants enrolled before 31 weeks), 6 weeks postpartum, and 6, 12, and 18 months postpartum
|
|
Maternal anxiety symptoms (mothers)
Zeitfenster: Baseline, 34-36 weeks of gestation (for participants enrolled before 31 weeks), 6 weeks postpartum, and 6, 12, and 18 months postpartum
|
Changes in anxiety symptoms.
Assessment method: The General Anxiety Questionnaire (GAD-7), a 7-item self-report measure.
Each item is scored from 0 to 3, with higher scores indicating more severe anxiety symptoms.
|
Baseline, 34-36 weeks of gestation (for participants enrolled before 31 weeks), 6 weeks postpartum, and 6, 12, and 18 months postpartum
|
|
Paternal depressive symptoms (partner)
Zeitfenster: Baseline, 34-36 weeks of gestation (for participants enrolled before 31 weeks), 6 weeks postpartum, and 6, 12, and 18 months postpartum
|
Changes in depressive symptoms.
Assessment method: The Edinburgh Postnatal Depression Scale (EPDS), a 10-item self-report measure.
Each item is scored from 0 to 3, with higher scores indicating more severe depressive symptoms.
|
Baseline, 34-36 weeks of gestation (for participants enrolled before 31 weeks), 6 weeks postpartum, and 6, 12, and 18 months postpartum
|
|
Paternal anxiety symptoms (partner)
Zeitfenster: Baseline, 34-36 weeks of gestation (for participants enrolled before 31 weeks), 6 weeks postpartum, and 6, 12, and 18 months postpartum
|
Changes in anxiety symptoms.
Assessment method: The General Anxiety Questionnaire (GAD-7), a 7-item self-report measure.
Each item is scored from 0 to 3, with higher scores indicating more severe anxiety symptoms.
|
Baseline, 34-36 weeks of gestation (for participants enrolled before 31 weeks), 6 weeks postpartum, and 6, 12, and 18 months postpartum
|
|
Psychological well-being (mothers, partners)
Zeitfenster: Baseline, 34-36 weeks of gestation (for participants enrolled before 31 weeks), 6 weeks postpartum, and 6, 12, and 18 months postpartum
|
Changes in subjective well-being.
Assessment method: The Well-Being Index (WHO-5), a 5-item self-report measure.
Each item is scored from 0 to 5, with higher scores indicating better subjective well-being.
|
Baseline, 34-36 weeks of gestation (for participants enrolled before 31 weeks), 6 weeks postpartum, and 6, 12, and 18 months postpartum
|
Andere Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Organisatorische Bereitschaft zur Umsetzung von Veränderungen
Zeitfenster: Gemessen vor der Einstellung
|
Die Bereitschaft der Organisation, Änderungen in der üblichen Pflege umzusetzen.
Bewertungsmethode: The Organizational Readiness Implementing Change (ORIC), eine Selbstberichtsmaßnahme mit 12 Punkten.
Jeder Punkt wird mit 1 bis 5 bewertet, wobei höhere Bewertungen auf eine größere Bereitschaft zur Umsetzung von Veränderungen hinweisen.
|
Gemessen vor der Einstellung
|
|
PHC-Eigenschaften
Zeitfenster: Gemessen vor der Einstellung
|
Größe der Bevölkerung, in der sich die PHC befindet, und Anzahl der PHC-Fachkräfte.
Bewertungsmethode: Vom Forschungsteam entwickelter Fragebogen
|
Gemessen vor der Einstellung
|
|
App quality (mothers, partners)
Zeitfenster: 12 months postpartum
|
Objective and subjective quality, and the perceived impact of the application.
Assessment method: The User Version of the Mobile Application Rating Scale (u-MARS), a 26-item self-report measure.
Each item is scored from 1 to 5, with higher scores indicating better app quality.
|
12 months postpartum
|
|
Implementation process
Zeitfenster: 12 months postpartum
|
App implementation process from the perspective of healthcare professionals involved in implementing complex interventions.
Assessment method: The Normalization Measure Development Questionnaire (NoMAD), a 20-item self-report measure.
Each item is scored from 1 to 5, with higher scores indicating more effective implementation processes.
|
12 months postpartum
|
|
Barriers and facilitators
Zeitfenster: 12 months postpartum
|
Identifies barriers and facilitators impacting the integration of the intervention into routine healthcare, drawing from the experiences of users and healthcare professionals.
Assessment method: Semi-structured interviews following the Normalization Process Theory (NPT) framework
|
12 months postpartum
|
|
Reasons for dropout (mothers, partners)
Zeitfenster: 12 months postpartum
|
Number and reasons (e.g., experienced miscarriage or stillbirth, lack of engagement with the app) for dropout among women and their partners.
Assessment method: Records and semi structured interviews.
|
12 months postpartum
|
|
Antenatal and postnatal risks (mothers, partners)
Zeitfenster: Baseline, 6 weeks postpartum
|
Measures both antenatal and postnatal risk factors.
Assessment method: The Antenatal Risk Questionnaire (ANRQ-R), a 11-item self-report measure.
Some items are scored from 1 to 5 and others are scored on categorical scale, with higher scores indicating greater risk.
|
Baseline, 6 weeks postpartum
|
|
Basic psychological needs (mothers, partners)
Zeitfenster: Baseline, 34-36 weeks of gestation (for participants enrolled before 31 weeks)
|
Measures the satisfaction and frustration of basic psychological needs.
Assessment method: The Basic Psychological Need Satisfaction and Frustration Scale - Short Form (BPNSFS), a 12-item self-report measure.
Each item is scored from 1 to 5, with higher scores indicating a higher need satisfaction (i.e., need satisfaction subscale) or a higher need frustration (i.e., need frustration subscale).
|
Baseline, 34-36 weeks of gestation (for participants enrolled before 31 weeks)
|
|
Maternal post-traumatic stress symptoms (mothers)
Zeitfenster: 6 weeks postpartum
|
Presence of post-traumatic stress symptoms after childbirth.
Assessment method: City Birth Trauma Scale (City-BiTS), a 5-item self-report measure.
A total of 4 items are scored from 0 to 3 and one item is scored from 0 to 1, with higher scores indicating greater severity of postnatal post-traumatic stress.
|
6 weeks postpartum
|
|
Maternal perceptions of childbirth (mothers)
Zeitfenster: 6 weeks postpartum
|
Measure of the perceived quality of the childbirth experience.
Assessment method: Childbirth Experience Questionnaire (CEQ-E), a 22-items self-report scale.
A total of 19 items range from 1 to 4. A total of 2 items range from 0 to 10. Higher scores indicate a more positive experience of childbirth.
|
6 weeks postpartum
|
|
Maternal breastfeeding experience (mothers)
Zeitfenster: 6 weeks postpartum; 6 months postpartum
|
Assessment method: Ad hoc instrument.
The instrument assesses infant feeding practices (2 items) and maternal satisfaction with breastfeeding (1 item), yielding a score ranging from 0 to 100.
Higher scores indicate greater satisfaction with breastfeeding.
|
6 weeks postpartum; 6 months postpartum
|
|
Maternal antenatal attachment (mothers)
Zeitfenster: 34-36 weeks of gestation (for participants enrolled before 31 weeks)
|
Measures the level of maternal antenatal attachment to the baby.
Assessment method: The Maternal Antenatal Attachment Scale (MAAS), a 19-item self-report measure.
Each item is scored from 1 to 5, with higher scores indicating stronger maternal antenatal attachment.
|
34-36 weeks of gestation (for participants enrolled before 31 weeks)
|
|
Paternal antenatal attachment (partners)
Zeitfenster: 34-36 weeks of gestation (for participants enrolled before 31 weeks)
|
Measures the level of paternal antenatal attachment to the baby.
Assessment method: The Paternal Antenatal Attachment Scale (PAAS), a 16-item self-report measure.
Each item is scored from 1 to 5, with higher scores indicating stronger paternal antenatal attachment.
|
34-36 weeks of gestation (for participants enrolled before 31 weeks)
|
|
Maternal postnatal attachment (mothers)
Zeitfenster: 6 weeks postpartum
|
Measures the level of maternal postnatal attachment to the baby.
Assessment method: The Maternal Postnatal Attachment Scale (MPAS), a 19-item self-report measure.
Each item is scored from 1 to 5, with higher scores indicating stronger maternal postnatal attachment.
|
6 weeks postpartum
|
|
Paternal postnatal attachment (fathers)
Zeitfenster: 6 weeks postpartum
|
Measures the level of postnatal attachment to the baby in both mothers and fathers.
Assessment method: The Paternal Postnatal Attachment Scale (PPAS), a 19-item self-report measure.
Each item is scored from 1 to 5, with higher scores indicating stronger paternal postnatal attachment.
|
6 weeks postpartum
|
|
Psychological flexibility (mothers, partner)
Zeitfenster: Baseline, 34-36 weeks of gestation (for participants enrolled before 31 weeks)
|
Measure of psychological flexibility.
Assessment method: Comprehensive assessment of Acceptance and Commitment Therapy processes (CompACT), a 10-item self-report scale.
Each item is scored from 1 to 7, with higher scores indicating greater psychological flexibilityTime
|
Baseline, 34-36 weeks of gestation (for participants enrolled before 31 weeks)
|
|
Partnership quality (mothers, partners)
Zeitfenster: Baseline, 34-36 weeks of gestation (for participants enrolled before 31 weeks)
|
Measures the quality of the marital or partnership relationship.
Assessment method: The Quality of Marriage Index (QMI), a 6-item self-report measure.
Some items are scored from 1 to 7 and others from 1 to 10, with higher scores indicating better relationship quality.
|
Baseline, 34-36 weeks of gestation (for participants enrolled before 31 weeks)
|
|
Parental role perception (mothers)
Zeitfenster: 6 months postpartum
|
Measures parents' perception of their competence in the parental role.
Assessment method: The Parental Sense of Competence scale (PSOC), a 21-item self-report measure.
Each item is scored from 1 to 6, with higher scores indicating a stronger sense of parental competence.
|
6 months postpartum
|
|
Coparenting dynamics (mothers, partners)
Zeitfenster: 6 months postpartum
|
Measures the dynamics of coparenting relationships.
Assessment method: The Coparenting Relationship Scale (CRS), a 14-item self-report measure.
Each item is scored from 0 to 6, with higher scores indicating more positive coparenting dynamics.
|
6 months postpartum
|
|
Mediterranean diet adherence (mothers, partners)
Zeitfenster: Baseline, 34-36 weeks of gestation (for participants enrolled before 31 weeks)
|
Measure of adherence to the mediterranean diet.
Assessment method: Mediterranean Diet Adherence Screener (MEDAS), a 14-items self-report instrument.
Each item score from 0 to 1. Higher scores indicate greater adherence to the mediterranean diet.
|
Baseline, 34-36 weeks of gestation (for participants enrolled before 31 weeks)
|
|
Maternal physical activity levels (mothers)
Zeitfenster: Baseline, 6 months postpartum
|
Measures physical activity levels in pregnant women and mothers.
Assessment method: The Pregnancy Physical Activity Questionnaire (PPAQ), a 33-item self-report measure.
Each item is scored from 0 to 5, with higher scores indicating higher levels of physical activity.
|
Baseline, 6 months postpartum
|
|
Physical condition (mothers)
Zeitfenster: Baseline, 6 months postpartum
|
Measures overall physical condition and the main components (i.e., cardiorespiratory fitness, muscular strength, speed-agility, and flexibility) in pregnant women and mothers.
Assessment method: The International FItness Scale (IFIS), a 5-item self-report measure.
Each item is scored from 1 to 5, with higher scores indicating better physical condition.
|
Baseline, 6 months postpartum
|
|
Child temperament (mothers)
Zeitfenster: 6 months postpartum
|
Measures various aspect of infant temperament.
Assessment method: The Infant Behavior Questionnaire-Revised Short Form (IBQ-R SF), a 37-item self-report measure.
Each item is scored from 1 to 7, with higher scores indicating a higher frequency of the specified temperament behavior.
|
6 months postpartum
|
|
Child development (mothers)
Zeitfenster: 6 months postpartum
|
Measures of various domains of infant development. Assessment method: Ages & Stages Questionnaires (ASQ-3), a self-report measure. Each milestone question is answered using one of three frequency options, which are converted into point values:
|
6 months postpartum
|
|
Life quality (mothers, partners)
Zeitfenster: 12 months postpartum
|
Measures the overall quality of life.
Assessment method: The European Quality of Life-5 Dimensions-5 Levels (EuroQol-5D-5L), a 5-item self-report measure.
Each item is scored from 1 to 5, with higher scores indicating worse quality of life
|
12 months postpartum
|
|
Identity (mothers, partners)
Zeitfenster: Baseline, 6 months postpartum
|
Measure of various domains of identity development.
Assessment method: Dimensions of Identity Development Scale (DIDS)., a 25-items self-report measure.
Each item is scored from 1 to 5, with higher scores indicating greater endorsement of the corresponding identity development dimension.
|
Baseline, 6 months postpartum
|
|
Economic data
Zeitfenster: 12 months postpartum
|
Measures healthcare service utilization and sick leave days over the previous year among participating women.
Assessment method: a post hoc semi-structured interview that collects information on emergency visits, hospital admissions, primary care visits (e.g., nurse, midwife, social worker), secondary care visits, and consultations with specialists.
|
12 months postpartum
|
Mitarbeiter und Ermittler
Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.
Sponsor
Ermittler
- Hauptermittler: Emma Motrico, PhD, University of Seville
Studienaufzeichnungsdaten
Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.
Haupttermine studieren
Studienbeginn (Geschätzt)
30. Mai 2026
Primärer Abschluss (Geschätzt)
30. Dezember 2027
Studienabschluss (Geschätzt)
30. März 2028
Studienanmeldedaten
Zuerst eingereicht
6. Mai 2026
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
25. Mai 2026
Zuerst gepostet (Tatsächlich)
29. Mai 2026
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
29. Mai 2026
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
25. Mai 2026
Zuletzt verifiziert
1. Mai 2026
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- EP-WP3-2025
- 101042139 (Andere Kennung: European Research Council (ERC))
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
NEIN
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Nein
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Nein
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Perinatale Depression
-
Universite du Quebec en OutaouaisFonds de la Recherche en Santé du Québec; Canadian Research Chair in Family...Unbekannt
-
University of PennsylvaniaNational Institute of Nursing Research (NINR)RekrutierungMorbidität;PerinatalVereinigte Staaten
-
Women and Infants Hospital of Rhode IslandEunice Kennedy Shriver National Institute of Child Health and Human Development...AbgeschlossenPsychische Gesundheit | IPV | PerinatalVereinigte Staaten
-
Puerta de Hierro University HospitalAbgeschlossenOxytocin | Neugeborenes | Stillen | Verbindung | PerinatalSpanien
-
University of PennsylvaniaMarch of DimesAktiv, nicht rekrutierend
-
University Hospital, Clermont-FerrandAbgeschlossenSchwangerschaft bezogen | Sitzendes Verhalten | Sitzende Zeit | Perinatale Probleme | Morbidität;PerinatalFrankreich
-
University of California, San FranciscoAbgeschlossenStillen | Stillen, Exklusiv | Nuckelflasche | Morbidität;PerinatalVereinigte Staaten
-
University of British ColumbiaWomen's Health Research Institute of British ColumbiaAktiv, nicht rekrutierendSchwangerschaftskomplikationen | Schwangerschaft bezogen | Morbidität;Perinatal
-
Johns Hopkins UniversityAbgeschlossenSchwangerschaftskomplikationen | Kaiserschnitt-Komplikationen | Morbidität;Perinatal
-
University of PittsburghNational Institute on Drug Abuse (NIDA)Noch keine RekrutierungRaucherentwöhnung | Tabakkonsum | Cannabiskonsum | PerinatalVereinigte Staaten